Latest news
Loading news…
SIRPant Immunotherapeutics develops an approach to elicit tumor-specific T-cells through one of two alternative means: in vivo or ex vivo.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
7
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Hummelstown, Pennsylvania, United States
Key People at SIRPant Immunotherapeutics
Chief Medical Officer
7
professional contacts at SIRPant Immunotherapeutics
Contact execs at SIRPant Immunotherapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to SIRPant Immunotherapeutics
Loading news…
FAQs about SIRPant Immunotherapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.